MONDAY, March 27, 2023 (HealthDay News) — While all Americans could benefit from proposed new limits on what’s called PM2.5 air pollution, new research indicates the change has the potential to benefit Black and low-income Americans the most. The limits being considered by the U.S. Environmental Protection Agency (EPA) couldContinue Reading
THURSDAY, March 23, 2023 (HealthDay News) — Tuberculosis cases climbed again in 2022, U.S. health officials announced Thursday. Still, the 5% increase, which amounted to 8,300 cases, didn’t reach higher pre-pandemic numbers, according to the U.S. Centers for Disease Control and Prevention. “The message is loud and clear — TBContinue Reading
WEDNESDAY, March 15, 2023 (HealthDay News) — Black patients are dying of pulmonary fibrosis, a devastating disease marked by progressive scarring of the lungs, at significantly younger ages than white patients. A new study probes factors contributing to earlier onset of disease, hospitalization and death in Black patients. The diseaseContinue Reading
SUNDAY, March 12, 2023 (HealthDay News) — Planning for a safe summer camp experience requires some extra steps if your child has asthma or allergies. An allergy expert noted that it’s a huge concern for parents. “Most kids heading off to summer camp for the first time wonder how they’llContinue Reading
THURSDAY, March 9, 2023 (HealthDay News) — Ongoing shortages of a medication that hospitals and emergency rooms rely upon to treat breathing problems are likely to worsen in coming days and weeks, experts warn. That’s because one of the two major U.S. suppliers of liquid albuterol, Akorn Pharmaceuticals, abruptly laidContinue Reading
TUESDAY, March 7, 2023 (HealthDay News) — A new study is enough to take your breath way: Nearly no place on Earth is free of air pollution, it found. The study “provides a deep understanding of the current state of outdoor air pollution and its impacts on human health. WithContinue Reading
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in Americans ages 60 and older. The panel’s recommendation was based largelyContinue Reading
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed by pharmaceutical giant Pfizer Inc. The sameContinue Reading
MONDAY, Feb. 27, 2023 (HealthDay News) – Children in Sweden’s capital can breathe a little easier. As Stockholm’s air has gotten cleaner, young people’s lungs have gotten stronger, new research shows. The findings could have implications for cities worldwide. While the adverse impact of air pollutants on kids’ lung healthContinue Reading
THURSDAY, Feb. 16, 2023 (HealthDay News) — Doctors could soon have a new tool to help diagnose chronic obstructive pulmonary disease (COPD). A questionnaire called CAPTURE successfully identified almost half of clinical trial participants who had moderate to severe forms of previously undiagnosed COPD, researchers report. “The goal with tryingContinue Reading